Skip to main content
OpenTrials

Clinical trial condition

Bone Marrow Diseases

Explore clinical trials studying Bone Marrow Diseases. Study availability and eligibility vary by location and protocol.

3,008 public trials 530 recruiting studies
Refine in advanced search Browse all conditions

Bone Marrow Diseases trial results

Completed

A Phase Ib Study of Panobinostat (LBH589) in Combination With 5-Azacitidine for Myelodysplastic Syndromes (MDS), Chronic Myelomonocytic Leukemia (CMML) or Acute Myeloid Leukemia (AML) Patients

NCT01613976

Conditions
Acute Myeloid Leukemia (AML), Bone Marrow Diseases, Chronic Disease, +15 more
Locations
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Nagoya, Aichi-ken, Japan
  • Novartis Investigative Site Kobe, Hyōgo, Japan
  • Novartis Investigative Site Sendai, Miyagi, Japan
View Trial Details
Completed

A Safety and Efficacy Study of LGH447 in Patients With Acute Myeloid Leukemia (AML) or High Risk Myelodysplastic Syndrome (MDS)

NCT02078609

Conditions
AML and High Risk MDS, Bone Marrow Diseases, Hematologic Diseases, +7 more
Locations
  • Novartis Investigative Site Ann Arbor, Michigan, United States
  • Novartis Investigative Site Prahran, Victoria, Australia
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Ulm, Germany
View Trial Details
Completed

Nilotinib and LDE225 in the Treatment of Chronic or Accelerated Phase Myeloid Leukemia in Patients Who Developed Resistance to Prior Therapy

NCT01456676

Conditions
Bone Marrow Diseases, Chronic Disease, Disease Attributes, +11 more
Locations
  • Novartis Investigative Site Toronto, Ontario, Canada
  • Novartis Investigative Site Marseille, France
  • Novartis Investigative Site Frankfurt, Germany
  • Novartis Investigative Site Ulm, Germany
View Trial Details
Completed

To Evaluate the Effects of Multiple Doses of Nilotinib on the Pharmacokinetics and Metabolism of Midazolam in CML Patients With Additional Extension Phase to Evaluate the Safety of Nilotinib

NCT01223898

Conditions
Bone Marrow Diseases, Chronic Disease, Chronic Myeloid Leukemia, +11 more
Locations
  • Novartis Investigative Site Frankfurt/M, Germany
  • Novartis Investigative Site Jena, Germany
  • Novartis Investigative Site Mannheim, Germany
  • Novartis Investigative Site Ulm, Germany
View Trial Details

Related conditions